Inspire Medical Systems (NYSE:INSP – Free Report) had its price target trimmed by Morgan Stanley from $230.00 to $220.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm ...
Q4 2024 Earnings Call Transcript February 10, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is ...
Hosted on MSN4d
Inspire Medical Systems’s (NYSE:INSP) Q4: Beats On RevenueMedical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results , with sales up 24.5% year on year ...
MORGANTOWN, W. Va.--(BUSINESS WIRE)--Infinity Natural Resources, Inc. (“Infinity”) (NYSE: INR) announced today that Infinity President and CEO Zack Arnold and EVP and CFO David Sproule will be joined ...
Shares of NYSE INSP opened at $188.77 on Friday. The company has a 50 day moving average of $189.32 and a 200 day moving average of $186.43. Inspire Medical Systems has a twelve month low of $123. ...
Medical technology company Inspire Medical Systems (NYSE:INSP) will be reporting results tomorrow after market close. Here’s what you need to know. Inspire Medical Systems beat analysts ...
MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative ...
Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue expectations , with sales up 24.5% year on year to $239.7 million.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results